Evaluation of VISIOCYT Bladder Cytology in Real Life (VISIOCYT2)
Evaluation of the Real-life Contribution of VISIOCYT Bladder Cytology in Patients With Suspected Bladder Tumor or in the Follow-up of a Bladder Tumor
Sponsor: Institut Paoli-Calmettes
This observational or N/A phase trial investigates Bladder Cancer and is currently actively recruiting participants. Institut Paoli-Calmettes leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
4 versions recorded-
Mar 2025 — Present [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting · Phase: NA → None
-
Sep 2024 — Mar 2025 [monthly]
Not Yet Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
-
Nov 2023 — Jul 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Institut Paoli-Calmettes
For direct contact, visit the study record on ClinicalTrials.gov .